You can use MeAgain with or instead of Lose It If you already use Lose It, the useful habits transfer naturally: logging meals, watching protein or macros, recording weight, checking patterns, and building consistency
A 2024 meta-analysis found tirzepatide users lost approximately 23% more body weight on average than semaglutide users at comparable timepoints, though baseline weight and adherence also influence outcomes
Renal impairment GLP-1 RAs are generally safe in patients with CKD and have demonstrated nephroprotective effects in the FLOW trial, where semaglutide significantly reduced the composite renal endpoint (hospitalization for acute kidney injury, sustained 50% decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, or renal death) in patients with type 2 diabetes and CKD [15]
Iqbal et al., 2025)
Together, they help you achieve that radiant glow we all chase
Finally, dont underestimate the power of small, non-medication tools
